Abstract
In the past few years, an increasing number of in situ gel forming systems have been reported in the literature for various biomedical applications, including drug delivery, cell encapsulation, and tissue repair. The possible mechanisms that lead to in situ gel formation are solvent removal, ionic cross-linkage, light-sensitive, pH change and temperature modulation. The ability to inject a drug incorporated into a polymer to a localized site and have the drug from a semi-solid depot has a number of advantages. The advantages include ease of application, localized and prolonged drug delivery. For these reasons a large number of in situ setting polymeric delivery systems have been developed and investigated. This article reviews the stimuli-sensitive polymers and the use of these polymers in parenterals, ocular, peroral, rectal, vagina, nasal, dermal and transdermal drug delivery.
Keywords: In situ, gels, mucosa, drug delivery system, cell encapsulation, tissue repair, ionic cross-linkage, light-sensitive, semi-solid depot, stimuli-sensitive polymers
Current Drug Therapy
Title: In Situ Gels Based Drug Delivery Systems
Volume: 6 Issue: 3
Author(s): Madhugiri P. Venkatesh, Purohit K. Liladhar, Teggin M.P. Kumar and Hosakote G. Shivakumar
Affiliation:
Keywords: In situ, gels, mucosa, drug delivery system, cell encapsulation, tissue repair, ionic cross-linkage, light-sensitive, semi-solid depot, stimuli-sensitive polymers
Abstract: In the past few years, an increasing number of in situ gel forming systems have been reported in the literature for various biomedical applications, including drug delivery, cell encapsulation, and tissue repair. The possible mechanisms that lead to in situ gel formation are solvent removal, ionic cross-linkage, light-sensitive, pH change and temperature modulation. The ability to inject a drug incorporated into a polymer to a localized site and have the drug from a semi-solid depot has a number of advantages. The advantages include ease of application, localized and prolonged drug delivery. For these reasons a large number of in situ setting polymeric delivery systems have been developed and investigated. This article reviews the stimuli-sensitive polymers and the use of these polymers in parenterals, ocular, peroral, rectal, vagina, nasal, dermal and transdermal drug delivery.
Export Options
About this article
Cite this article as:
P. Venkatesh Madhugiri, K. Liladhar Purohit, M.P. Kumar Teggin and G. Shivakumar Hosakote, In Situ Gels Based Drug Delivery Systems, Current Drug Therapy 2011; 6 (3) . https://dx.doi.org/10.2174/157488511796392004
DOI https://dx.doi.org/10.2174/157488511796392004 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glucocorticoids: Structure, Signaling and Molecular Mechanisms in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Current Molecular Medicine Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?
Cardiovascular & Hematological Agents in Medicinal Chemistry Review of and Perspectives on the Toxicology of Graphene-based Materials
Current Drug Metabolism Biologics: An Update and Challenge of Their Pharmacokinetics
Current Drug Metabolism CB-12181, a New Azasugar-Based Matrix Metalloproteinase/Tumor Necrosis Factor-α Converting Enzyme Inhibitor, Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and Retinal Neovascularization in Vivo
Current Neurovascular Research Nitric Oxide-Derived Oxidants with a Focus on Peroxynitrite: Molecular Targets,Cellular Responses and Therapeutic Implications
Current Pharmaceutical Design Endothelial Dysfunction and Atherosclerosis: Focus on Novel Therapeutic Approaches
Recent Patents on Cardiovascular Drug Discovery Effect of Intravitreal Injection of Aflibercept on Cardiovascular Risk Parameters in Patients with Neovascular Age-Related Macular Degeneration
Current Reviews in Clinical and Experimental Pharmacology Gene Therapy for Cardiovascular Diseases
Current Pharmaceutical Design Systemic Adverse Drug Reactions Secondary to Anti-VEGF Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration
Current Vascular Pharmacology Treatment of Chronic Peripheral Arterial Disease
Current Vascular Pharmacology Drug Delivery to the Posterior Segment of the Eye: Challenges and Opportunities
Drug Delivery Letters Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Disease More Effectively
CNS & Neurological Disorders - Drug Targets The Protective Effects of Natural Products on Blood-Brain Barrier Breakdown
Current Medicinal Chemistry Metabolism and Pharmacological Mechanisms of Active Ingredients in <i>Erigeron breviscapus</i>
Current Drug Metabolism Pigment Epithelium-derived Factor (PEDF) and Cardiometabolic Disorders
Current Pharmaceutical Design Anthocyanins As Modulators of Cell Redox-Dependent Pathways in Non-Communicable Diseases
Current Medicinal Chemistry Neuropharmacological Aspects of Crocus sativus L.: A Review of Preclinical Studies and Ongoing Clinical Research
CNS & Neurological Disorders - Drug Targets Antiphospholipid Syndrome as a Neurological Disease
Current Rheumatology Reviews Therapeutic Potential of Erythropoietin in Retinal and Optic Nerve Diseases
CNS & Neurological Disorders - Drug Targets